Consensus document and recommendations on the use of natriuretic peptides in clinical practice

详细信息    查看全文

• 作者：D.A. Pascual-Figal^a ; J. Casademont^b ; ^{jcasademont@santpau.cat" class="auth_mail" title="E-mail the corresponding author} ; J.M. Lobos^c ; P. Piñ ; era^d ; A. Bayé ; s-Genis^a ; J. Ordó ; ñ ; ez-Llanos^a ; J.R. Gonzá ; lez-Juanatey^a
• 关键词：Natriuretic peptides ; B-type natriuretic peptide ; Aminoterminal pro-B-type natriuretic peptide ; Heart failure
• 刊名：Revista Clínica Española (English Edition)
• 出版年：2016
• 出版时间：August-September 2016
• 年：2016
• 卷：216
• 期：6
• 页码：313-322
• 全文大小：1205 K

文摘

Natriuretic peptides are a useful laboratory tool for the diagnosis, prognosis and treatment of patients with heart failure. Natriuretic peptides are used in various healthcare settings (consultations, emergency department, hospitalization, laboratory) and by various primary care and specialized professionals. However, their use in clinical practice is still scare and uneven. Properly using and interpreting natriuretic peptides in clinical practice requires a minimum of prelaboratory (pathophysiology), laboratory (methods) and postlaboratory (interpretation and integration of clinical data) expertise. The objective of this consensus document, developed by several scientific societies, is to update the necessary concepts and expertise on natriuretic peptides that enable its application in the diagnosis, prognosis and treatment of heart failure, in various healthcare environments.